Sg3 Management, LLC Intra Cellular Therapies, Inc. Transaction History

Sg3 Management, LLC

  • $0
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$30.8 - $39.51 $837,144 - $1.07 Million
-27,180 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$23.34 - $32.22 $634,381 - $875,739
27,180 New
27,180 $864,000
Q3 2020

Nov 13, 2020
SELL
$17.61 - $31.86 $616,350 - $1.12 Million
-35,000 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$14.35 - $26.64 $502,250 - $932,400
35,000 New
35,000 $898,000

Others Institutions Holding ITCI

# of Institutions
378
Shares Held
84.7M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.17B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email